Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Slagle who wrote (22301)	10/20/2005 11:22:44 AM
From: Paul Senior	Read Replies (1) \| Respond to of 78567

Slagle, I'm avoiding MRK - have sold, taken lumps, and moved on. Sorry I can't say the same about PFE and BMY - both of which I still have a few shares of and am suffering with. I guess MRK's div. is more secure than most others of the big pharmas (based on a cursory look at cash/debt per Yahoo). Whether dividend is actually secure, who knows? With all the institutional holders in these companies, a div. cut would send a very bad signal, imo. --------- SGP a few years back when they got in trouble, cut their div. It's possible that MRK, BMY might be on the same path. -- What a change in fortunes for stockholders the past few years have wrought: finance.yahoo.com